বুলগেরিয়া -
বুলগেরিয় -
БАБХ (Българска агенция по безопасност на храните)
bravoxin 10 bg
intervet international b.v - С. perfringes тип анатоксина, С. perfringes тип b и c анатоксина, С. perfringes тип d анатоксина, С. chauvoei цялата култура, с. Нова анатоксина, С. septicum анатоксина, анатоксина c. tetani, С. sordelli анатоксина, анатоксина С. heamolyticum - инжекционна суспензия - ≥ 0,5 iu, ≥ 18,2 iu, ≥ 5,3 iu, meets ph.eur., ≥ 3,8 iu, ≥ 4,6 iu, ≥ 4,9 iu, ≥ 4,4 iu, ≥ 11,7 iu - говеда, овце
বুলগেরিয়া -
বুলগেরিয় -
БАБХ (Българска агенция по безопасност на храните)
covexin 8
zoetis belgium sa - С. chauvoei (цялата култура, инактивированная); В. филтри тип b и c (бета-анатоксин); В. филтри тип d (Епсилон анатоксина); В. haemolyticum; В. septicum; ее. septicum анатоксина; ее. нов тип b анатоксина; ее. tetani анатоксина - инжекционна суспензия - 30% v/v that induce at least 90% guinea pig survival; ≥ 13.1 u1; ≥ 7 u1; ≥ 11.7 u2; ≥ 2.8 u1; ≥ 2.1 u1; ≥ 1.6 u1 - говеда, овце
বুলগেরিয়া -
বুলগেরিয় -
БАБХ (Българска агенция по безопасност на храните)
toxipra - s7
laboratorios hipra, s.a. - Клостридии филтри тип b, c и d; clostridium нов тип b; с clostridium septicum; бактерии clostridium chauvoei; с clostridium sordellii - инжекционна суспензия - ≥ 10 ui antitoxine β/ml of serum; ≥ 5 ui antitoxine έ/ml of serum; ≥ 3.5 ui antitoxine α/ml of serum; ≥ 2.5 ui antitoxine α/ml o - агнета, говеда, кози, овце, ярета
বুলগেরিয়া -
বুলগেরিয় -
БАБХ (Българска агенция по безопасност на храните)
covexin 10 suspension for injection for sheep and cattle
zoetis belgium sa - c. perfringens type a toxoid, c. perfringens type b & c (β) toxoid, c. perfringens type d (ε) toxoid, c. chauvoei whole culture, c. novyi toxoid, c. septicum toxoid, c. tetani toxoid, c. sordellii toxoid, c. haemolyticum toxoid - инжекционна суспензия - ≥ 0, 9 u на степен 3, ≥ 12, 4 u на степен 1, ≥ 5, 1 u на степен 1, meets ph eur. ; ≥ 1, 2 u на степен 1, ≥ 3, 6 u на степен 1, ≥ - говеда, овце
ইউরোপীয় ইউনিয়ন -
বুলগেরিয় -
EMA (European Medicines Agency)
ultomiris
alexion europe sas - ravulizumab - Хемоглобинурия, пароксизма - Селективни имуносупресори - paroxysmal nocturnal haemoglobinuria (pnh)ultomiris is indicated in the treatment of adult and paediatric patients with a body weight of 10 kg or above with pnh:- in patients with haemolysis with clinical symptom(s) indicative of high disease activity. - in patients who are clinically stable after having been treated with eculizumab for at least the past 6 months (see section 5. atypical haemolytic uremic syndrome (ahus)ultomiris is indicated in the treatment of patients with a body weight of 10 kg or above with ahus who are complement inhibitor treatment-naïve or have received eculizumab for at least 3 months and have evidence of response to eculizumab (see section 5. generalized myasthenia gravis (gmg)ultomiris is indicated as an add-on to standard therapy for the treatment of adult patients with gmg who are anti-acetylcholine receptor (achr) antibody-positive. neuromyelitis optica spectrum disorder (nmosd)ultomiris is indicated in the treatment of adult patients with nmosd who are anti-aquaporin 4 (aqp4) antibody-positive (see section 5. ultomiris is indicated in the treatment of adult patients with paroxysmal nocturnal haemoglobinuria (pnh):- in patients with haemolysis with clinical symptom(s) indicative of high disease activity. - in patients who are clinically stable after having been treated with eculizumab for at least the past 6 months. ultomiris is indicated in the treatment of adult patients with atypical haemolytic uremic syndrome (ahus) who are complement inhibitor treatment-naïve or have received eculizumab for at least 3 months and have evidence of response to eculizumab.
ইউরোপীয় ইউনিয়ন -
বুলগেরিয় -
EMA (European Medicines Agency)
solymbic
amgen europe b.v. - адалимумаб - arthritis, psoriatic; spondylitis, ankylosing; crohn disease; colitis, ulcerative; hidradenitis suppurativa; psoriasis; arthritis, rheumatoid - Имуносупресори - Моля, направете справка в раздел 4. 1 от Кратката характеристика на продукта в документа с информация за продукта.
বুলগেরিয়া -
বুলগেরিয় -
БАБХ (Българска агенция по безопасност на храните)
cobactan la 7, 5 % 75 mg/ml
intervet international b.v. - cefquinome (като сулфат) - инжекционна суспензия - 75 mg/ml - говеда
বুলগেরিয়া -
বুলগেরিয় -
БАБХ (Българска агенция по безопасност на храните)
ataxxa 1250 mg
krka - Перметрин, Имидаклоприд - разтвор за прилагане върху ограничен участък - 1250 mg / пипета; 250 mg / пипета - кучета